PHARMARESEARCH BIO Co., Ltd. (XKON:217950)
South Korea
· Delayed Price · Currency is KRW
37,200
-1,800 (-4.62%)
At close: Aug 14, 2025, 3:30 PM KST
PHARMARESEARCH BIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
FY 2014 | FY 2014 |
Dec '14 Dec 31, 2014 | Mar '14 Mar 31, 2014 |
Net Income | -883.52 | -246.41 |
Depreciation & Amortization | 4.69 | 3.19 |
Asset Writedown & Restructuring Costs | - | 1 |
Other Operating Activities | 412.29 | 61.33 |
Change in Accounts Receivable | 73.33 | -55 |
Change in Other Net Operating Assets | 6.56 | -16.1 |
Operating Cash Flow | -386.65 | -251.99 |
Capital Expenditures | -29.1 | - |
Other Investing Activities | -42.67 | - |
Investing Cash Flow | -71.76 | - |
Short-Term Debt Issued | - | 239.86 |
Long-Term Debt Issued | - | 1,000 |
Total Debt Issued | - | 1,240 |
Short-Term Debt Repaid | - | -292.96 |
Total Debt Repaid | -50.67 | -292.96 |
Net Debt Issued (Repaid) | -50.67 | 946.9 |
Issuance of Common Stock | - | 98.18 |
Financing Cash Flow | -50.67 | 1,045 |
Net Cash Flow | -509.08 | 793.09 |
Free Cash Flow | -415.75 | -251.99 |
Free Cash Flow Margin | -233.32% | -78.46% |
Free Cash Flow Per Share | -10393.76 | -6299.54 |
Change in Working Capital | 79.89 | -71.1 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.